Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M410355200 on September 27, 2004

J. Biol. Chem., Vol. 279, Issue 52, 53955-53962, December 24, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/52/53955    most recent
M410355200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pearce, A. C.
Right arrow Articles by Vigorito, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pearce, A. C.
Right arrow Articles by Vigorito, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Vav1 and Vav3 Have Critical but Redundant Roles in Mediating Platelet Activation by Collagen*

Andrew C. Pearce{ddagger}§, Yotis A. Senis{ddagger}§, Daniel D. Billadeau||, Martin Turner**{ddagger}{ddagger}, Steve P. Watson{ddagger}§§§, and Elena Vigorito**

From the {ddagger}Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, United Kingdom, the **Laboratory for Lymphocyte Signalling and Development, Molecular Immunology Programme, The Babraham Institute, Babraham, Cambridge CB2 4AT, United Kingdom, the ||Department of Immunology, Mayo Graduate School, Mayo Clinic, Rochester, Minnesota 55905, and the §Centre for Cardiovascular Studies, Institute of Biomedical Research, Division of Medical Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom

Vav family proteins are guanine nucleotide exchange factors for the Rho/Rac family of small GTP-binding proteins. In addition, they have domains that mediate protein-protein interactions, including one Src homology 2 (SH2) and two Src homology 3 (SH3) domains. Vav1, Vav2, and Vav3 play a crucial role in the regulation of phospholipase C{gamma} (PLC{gamma}) isoforms by immuno-tyrosine-based activation motif (ITAM)-coupled receptors, including the T- and B-cell antigen receptors. We have reported in platelets, however, that Vav1 and Vav2 are not required for activation of PLC{gamma}2 in response to stimulation of the ITAM-coupled collagen receptor glycoprotein VI (GPVI). Here we report that Vav3 is tyrosinephosphorylated upon activation of GPVI but that Vav3-deficient platelets also exhibit a normal response upon activation of the ITAM receptor. In sharp contrast, platelets deficient in both Vav1 and Vav3 show a marked inhibition of aggregation and spreading upon activation of GPVI, which is associated with a reduction in tyrosine phosphorylation of PLC{gamma}2. The phenotype of Vav1/2/3 triple-deficient platelets is similar to that of Vav1/3 double-deficient cells. These results demonstrate that Vav3 and Vav1 play crucial but redundant roles in the activation of PLC{gamma}2 by GPVI. This is the first time that absolute redundancy between two protein isoforms has been observed with respect to the regulation of PLC{gamma}2 in platelets.


Received for publication, September 9, 2004

* This work was supported in part by the Wellcome Trust, the British Heart Foundation, and the Biotechnology and Biological Sciences Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger}{ddagger} Holds a Medical Research Council Senior Fellowship.

§§ Holds a British Heart Foundation Research Chair.

A Wellcome Trust Prize Student. To whom correspondence should be addressed. Tel.: 44-121-4158679; Fax: 44-121-4146919; E-mail: a.c.pearce{at}bham.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
Y. A. Senis, M. G. Tomlinson, S. Ellison, A. Mazharian, J. Lim, Y. Zhao, K. N. Kornerup, J. M. Auger, S. G. Thomas, T. Dhanjal, et al.
The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis
Blood, May 14, 2009; 113(20): 4942 - 4954.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
N. A. Bezman, L. Lian, C. S. Abrams, L. F. Brass, M. L. Kahn, M. S. Jordan, and G. A. Koretzky
Requirements of SLP76 tyrosines in ITAM and integrin receptor signaling and in platelet function in vivo
J. Exp. Med., August 4, 2008; 205(8): 1775 - 1788.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Kafri, O. Dahan, J. Levy, and Y. Pilpel
Preferential protection of protein interaction network hubs in yeast: Evolved functionality of genetic redundancy
PNAS, January 29, 2008; 105(4): 1243 - 1248.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. L. J. Fuller, J. A. E. Williams, M. G. Tomlinson, J. A. Eble, S. L. Hanna, S. Pohlmann, K. Suzuki-Inoue, Y. Ozaki, S. P. Watson, and A. C. Pearce
The C-type Lectin Receptors CLEC-2 and Dectin-1, but Not DC-SIGN, Signal via a Novel YXXL-dependent Signaling Cascade
J. Biol. Chem., April 27, 2007; 282(17): 12397 - 12409.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Suzuki-Inoue, G. L. J. Fuller, A. Garcia, J. A. Eble, S. Pohlmann, O. Inoue, T. K. Gartner, S. C. Hughan, A. C. Pearce, G. D. Laing, et al.
A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2
Blood, January 15, 2006; 107(2): 542 - 549.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement